News/Business

Drugmaker Regeneron Pharmaceuticals will buy genetic testing firm 23andMe Holding for $256 million USD through a bankruptcy auction, the companies said on Monday.Regeneron said it will comply with 23andMe's privacy policies and applicable laws with respect to the use of customer  data and that it is ready to detail its intended use of the data to a court-appointed overseer.The bankruptcy proceedings, filed in March, had drawn scrutiny from lawmakers who warned that millions of customers' genetic data could be sold to unscrupulous buyers.23andMe last month agreed to allow a court-appointed overseer for the company's handling of customers' genetic information and its security policies during the bankruptcy.The company has collected genetic data from 15 million customers who ordered its DNA t...

After U.S. President Donald Trump took office, sociologist Travers — who goes by one name — nixed plans to attend the North American Society for the Sociology of Sport (NASSS) conference in Seattle this November. Travers, a full professor at Simon Fraser University in Burnaby, B.C., is the president-elect of NASSS. But as a trans person, they are wary of visiting the U.S. at a time when the Trump administration is rolling back transgender rights."[I] will not be travelling to the United States right now because it feels very dangerous to do so," said Travers.The sociologist soon realized the problem was widespread: around 40 per cent of NASSS's 600 members live in Canada, and many of them reported that they, too, don't want to attend the Seattle conference, due to reports of increased scru...